We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medicines Company | NASDAQ:MDCO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.90 | 84.00 | 84.94 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * Kelly John C. | 2. Issuer Name and Ticker or Trading Symbol MEDICINES CO /DE [ MDCO ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 1/6/2020 | D | 32148 | D | (1)(2) | 0 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option | $16 | 9/26/2019 | G | V | 25000 (3) | 5/26/2014 | 4/26/2021 | Common Stock | 25000 | $0 | 0 | D | |||
Stock Option | $16 | 9/26/2019 | G | V | 25000 (3) | 5/26/2014 | 4/26/2021 | Common Stock | 25000 | $0 | 25000 | I | By trust | ||
Stock Option | $18.18 | 9/26/2019 | G | V | 13259 (3) | 5/26/2012 | 5/26/2021 | Common Stock | 13259 | $0 | 0 | D | |||
Stock Option | $18.18 | 9/26/2019 | G | V | 13259 (3) | 5/26/2012 | 5/26/2021 | Common Stock | 13259 | $0 | 13259 | I | By trust | ||
Stock Option | $21.14 | 9/26/2019 | G | V | 12039 (3) | 5/22/2013 | 5/22/2022 | Common Stock | 12039 | $0 | 0 | D | |||
Stock Option | $21.14 | 9/26/2019 | G | V | 12039 (3) | 5/22/2013 | 5/22/2022 | Common Stock | 12039 | $0 | 12039 | I | By trust | ||
Stock Option | $33.13 | 9/26/2019 | G | V | 9763 (3) | 5/30/2014 | 5/30/2023 | Common Stock | 9763 | $0 | 0 | D | |||
Stock Option | $33.13 | 9/26/2019 | G | V | 9763 (3) | 5/30/2014 | 5/30/2023 | Common Stock | 9763 | $0 | 9763 | I | By trust | ||
Stock Option | $27.78 | 9/26/2019 | G | V | 10016 (3) | 5/29/2015 | 5/29/2024 | Common Stock | 10016 | $0 | 0 | D | |||
Stock Option | $27.78 | 9/26/2019 | G | V | 10016 (3) | 5/29/2015 | 5/29/2024 | Common Stock | 10016 | $0 | 10016 | I | By trust | ||
Stock Option | $28.14 | 9/26/2019 | G | V | 16512 (3) | 5/28/2016 | 5/28/2025 | Common Stock | 16512 | $0 | 0 | D | |||
Stock Option | $28.14 | 9/26/2019 | G | V | 16512 (3) | 5/28/2016 | 5/28/2025 | Common Stock | 16512 | $0 | 16512 | I | By trust | ||
Stock Option | $37.22 | 9/26/2019 | G | V | 9700 (3) | 5/26/2017 | 5/26/2026 | Common Stock | 9700 | $0 | 0 | D | |||
Stock Option | $37.22 | 9/26/2019 | G | V | 9700 (3) | 5/26/2017 | 5/26/2026 | Common Stock | 9700 | $0 | 9700 | I | By trust | ||
Stock Option | $39.39 | 9/26/2019 | G | V | 8577 (3) | 5/25/2018 | 5/25/2027 | Common Stock | 8577 | $0 | 0 | D | |||
Stock Option | $39.39 | 9/26/2019 | G | V | 8577 (3) | 5/25/2018 | 5/25/2027 | Common Stock | 8577 | $0 | 8577 | I | By trust | ||
Stock Option | $33.86 | 9/26/2019 | G | V | 9141 (3) | 5/31/2019 | 5/31/2028 | Common Stock | 9141 | $0 | 0 | D | |||
Stock Option | $33.86 | 9/26/2019 | G | V | 9141 (3) | 5/31/2019 | 5/31/2028 | Common Stock | 9141 | $0 | 9141 | I | By trust | ||
Stock Option | $16.00 | 1/6/2020 | D | 25000 | (4) | (4) | Common Stock | 25000 | $0 | 0 | I | By trust | |||
Stock Option | $18.18 | 1/6/2020 | D | 13259 | (4) | (4) | Common Stock | 13269 | $0 | 0 | I | By trust | |||
Stock Option | $21.14 | 1/6/2020 | D | 12039 | (4) | (4) | Common Stock | 12039 | $0 | 0 | I | By trust | |||
Stock Option | $33.13 | 1/6/2020 | D | 9763 | (4) | (4) | Common Stock | 9763 | $0 | 0 | I | By trust | |||
Stock Option | $27.78 | 1/6/2020 | D | 10016 | (4) | (4) | Common Stock | 10016 | $0 | 0 | I | By trust | |||
Stock Option | $37.22 | 1/6/2020 | D | 9700 | (4) | (4) | Common Stock | 9700 | $0 | 0 | I | By trust | |||
Stock Option | $28.14 | 1/6/2020 | D | 16512 | (4) | (4) | Common Stock | 16512 | $0 | 0 | I | By trust | |||
Stock Option | $39.39 | 1/6/2020 | D | 8577 | (4) | (4) | Common Stock | 8577 | $0 | 0 | I | By trust | |||
Stock Option | $34.81 | 1/6/2020 | D | 8410 | (4) | (4) | Common Stock | 8410 | $0 | 0 | D | ||||
Stock Option | $33.86 | 1/6/2020 | D | 9141 | (4) | (4) | Common Stock | 9141 | $0 | 0 | I | By trust |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Kelly John C. 8 SYLVAN WAY PARSIPPANY, NJ 07054 | X |
Signatures | ||
/s/ Stephen M. Rodin, Attorney-in-Fact for John C. Kelly | 1/6/2020 | |
**Signature of Reporting Person | Date |
1 Year Medicines Chart |
1 Month Medicines Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions